miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3
Authors
Keywords
Hepatocellular carcinoma, miR-582-5p, CDK1, AKT3, CyclinD1
Journal
TUMOR BIOLOGY
Volume 36, Issue 11, Pages 8309-8316
Publisher
Springer Nature
Online
2015-05-23
DOI
10.1007/s13277-015-3582-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer
- (2014) Nicola Valeri et al. CANCER CELL
- MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma
- (2014) Lingxiang Yu et al. Cancer Epidemiology
- A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
- (2013) Karoline Kollmann et al. CANCER CELL
- MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1
- (2013) Gui-Jun Yan et al. CANCER LETTERS
- Millepachine, a novel chalcone, induces G 2 /M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo
- (2013) Wenshuang Wu et al. CARCINOGENESIS
- Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression
- (2013) Keita Uchino et al. MOLECULAR THERAPY
- Diversifying microRNA sequence and function
- (2013) Stefan L. Ameres et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma
- (2013) H J Bae et al. ONCOGENE
- miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
- (2013) Rounak Nassirpour et al. PLoS One
- miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1
- (2013) Yanhua Liu et al. PLoS One
- miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma
- (2012) G. Shen et al. CARCINOGENESIS
- miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
- (2012) Xiaolan Zhu et al. FEBS LETTERS
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
- (2012) Wei-Chih Tsai et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma
- (2012) Tsung-Chieh Shih et al. JOURNAL OF HEPATOLOGY
- PI3K signalling: the path to discovery and understanding
- (2012) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
- (2010) Chye-Sun Ong et al. CANCER LETTERS
- miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway
- (2010) Fu Yang et al. HEPATOLOGY
- microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
- (2010) Julja Burchard et al. Molecular Systems Biology
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival
- (2008) J. Li et al. CLINICAL CANCER RESEARCH
- GSK-3β regulates cyclin D1 expression: A new target for chemotherapy
- (2007) Fumi Takahashi-Yanaga et al. CELLULAR SIGNALLING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now